Defence Completes 2nd Tranche of Financing

Defence Completes 2nd Tranche of Financing

Vancouver, BC, Canada, March 22nd, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2nd...